JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Therapy

Clinical trial NCT05164848 · UNKNOWN

Trial details

NCT number: NCT05164848
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Squamous Carcinoma

Start date: 2021-12-25
Primary completion: 2023-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.